Seminar · Dec 8, 2026
Digital Cognitive Assessments for Early Alzheimer’s Clinical Trials
Karra Harrington, PhD, Cogstate
We use cookies for analytics.
Seminar, Hosted by Fralin Biomedical Research Institute at VTC, Virginia Tech
Washington University School of Medicine
John Morris examines how blood-based biomarkers and anti-amyloid therapies have changed the clinical evaluation of early symptomatic Alzheimer disease. He discusses the role of timely and accurate diagnosis in identifying patients who may benefit from treatment.
Seminar · Dec 8, 2026
Karra Harrington, PhD, Cogstate
Seminar · Dec 10, 2026
Lucía Crivelli, Fleni +2
Seminar · Nov 18, 2026
Stephanie Vyverberg
Funding · Closes Feb 5, 2027
National Institutes of Health